SkyePharma attracts interest

Article Abstract:

SkyePharma PLC of the United Kingdom is looking for a merger. Many major pharmaceutical companies are expressing interest, notably AstraZeneca PLC, Novartis AG, Merck and Co., Biovalve Technologies Inc. and Endo Pharmaceuticals Inc. The medication and pharmaceutical drug delivery systems maker has a market valuation of approximately 303 million Euros ($525 million).

Acquisitions and mergers, SkyePharma PLC, SKYEY

---

AstraZeneca is on prowl outside its own lab walls

Article Abstract:

AstraZeneca PLC of the United Kingdom is following a trend in the pharmaceutical sector to purchase licensing agreements for promising medications developed at other laboratories. The pharmaceutical giant has spent $1.6 billion on new medication licensing agreements in the past several months.

Forecasts, trends, outlooks, AstraZeneca PLC, AZN, Industry forecasts

---

Big drug makers take a pass on Serono

Article Abstract:

Serano S.A. of Switzerland is struggling to find a buyer after overtures from several major pharmaceutical companies. The biotechnology interest was seeking approximately $15 billion which analysts considered high. Shares are up 25 percent to $842.28 since the company was put on the block.

Acquisitions & mergers, Switzerland, Drugs, Biotechnology industry, Mergers, acquisitions and divestments, Biotechnology industries, Company acquisition/merger

Similar abstracts:

• Abstracts: Fortis net rises 94%, efficiency plan is set. ING, Fortis post higher profits; Aegon net falls. ABN Amro's net profit falls 5.6%: loan loss provisions, lower special gains are cited for quarter
• Abstracts: Don Vicenti Casereccia Fideos con Hueve Estilo Casero. Vive Soy Barritas Con Soja. Desgras Barra Con Cereals
• Abstracts: Schwartau Corny Cereal Bar. Finax Nordic Flakes Cereal
• Abstracts: Big oil firms join hunt for natural gas in U.S. Oil Companies reap cash windfall from price surge. Pursuit of new oil supplies runs into a bottleneck
• Abstracts: Delphi delays bid to void Union pacts. Ford posts $1.19 billion loss as revenue drops nine percent. Ford posts net loss of $123 million

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.